Carmen Castrillo-Viguera

Suggest Changes
  • Citations Per Year
Learn More
BACKGROUND Subcutaneous (SC) peginterferon beta-1a and SC interferon beta-1a (IFN beta-1a) have demonstrated efficacy in treating relapsing-remitting multiple sclerosis (RRMS) but have never been(More)
  • 1